Similarities and distinctions in the activation of the Candida glabrata Pdr1 regulatory pathway by azole and non-azole drugs
2024
How Different Drugs Affect Candida glabrata's Resistance Mechanisms
publication
Evidence: high
Author Information
Author(s): Conway Thomas P., Vu Bao Gia, Beattie Sarah R., Krysan Damian J., Moye-Rowley W. Scott
Primary Institution: University of Iowa
Hypothesis
The study investigates how azole and non-azole drugs activate the Pdr1 regulatory pathway in Candida glabrata.
Conclusion
The study found that phenothiazine drugs induce a rapid and significant increase in CDR1 expression compared to azole drugs.
Supporting Evidence
- Fluphenazine and its derivative CWHM-974 induce CDR1 expression more rapidly than fluconazole.
- Phenothiazines activate the Pdr1 pathway through mechanisms that overlap but are distinct from azole drugs.
- Loss of PDR1 increases susceptibility to both azole and phenothiazine drugs.
Takeaway
This study shows that some drugs can make yeast more resistant to treatment, and different drugs work in different ways.
Methodology
The study used a firefly luciferase reporter gene to measure CDR1 promoter activation in response to different drugs.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website